Clinical Research Division, Fred Hutch
Public Health Sciences Division, Fred Hutch
Dr. Jeannine McCune is a clinical pharmacologist who focuses on hematopoietic cell transplantation and pediatric cancer. She studies the clinical use of anti-cancer drugs as well as drugs that suppress the immune system to prevent or treat cancer.
Her work also evaluates the influence of genetics on an individual’s drug response. She has received several major National Institutes of Health grants for personalized medicine studies in children and adults with cancer. In addition to clinical pharmacology, her research interests include pharmacokinetics (studying the movement, or uptake, of drugs within the body).
Professor, Department of Pharmacy
University of Washington
B.S., Pharmacy, Magna Cum Laude, University of Pittsburgh, 1993
Pharm.D., University of North Carolina Chapel Hill, 1995
Pharmacogenetics of Cyclophosphamide ADRs in Children, 1 R21 CA162059-01A2. September 2011-August 2014. Principal Investigator.
Pharmacogenetics in children with high-risk neuroblastoma, 1R03CA178104-01. September 2013-September 2015. Principal Investigator.
Ancillary Biomarker Studies to ANBL12P1, Melphalan Pharmacokinetics.” Cook Children’s Foundation. June 2013-May 2015. $25,000. Principal Investigator.
Impact of bone metastasis and skeletal related events (SREs) upon survival in metastatic castration resistant prostate cancer., April 2013-March 2015. Co-investigator. Principal Investigator: Scott D. Ramsey, MD, PhD, HICOR.
Choosing Wisely: Colony-stimulating factors, October 2013-September 2014. Co-investigator. Principal Investigator: Scott D. Ramsey, MD, PhD, HICOR.